Sunday, September 4, 2022
Saturday, August 27, 2022
TEAL TIME
She loved little things
It’s that
time again – September is Ovarian Cancer Awareness Month. Time to put on your teal cap and reach for
your wallet. This link tells you what
more you might consider doing.
V
She
Sunday, August 21, 2022
OF DOGS AND NANOYUBES
Linda and Ella
Twelve years ago
We have
known for some timethat dogs can detect ovarian cancer with their acute sense of
smell. Well, to be safe I ought to say
that some dgs can detect OVCA sometimes. Well, it now appears that we humans can
do it, too – with an expensive tool called a nanotube, developed and tested at
Sloan Kettering. Presumably it is more
sensitive than a dog, or else they wouldn’t be bragging about it. So, good for them. But, you can’t pet a nanotube!
https://www.drugdiscoverynews.com/a-molecular-nose-sniffs-out-ovarian-cancer-15462
Monday, August 8, 2022
MORE ON ASPIRIN AND OVCA
Linda in Athens
We have
discussed this before. A recent meta-analysis
confirms that continued use of low-dose aspirin significantly reduces the risk
of contracting OVCA, (A meta-analysis is
a fancy way of combining the results of many individual studies.) Negative factors include increase in risk of
internal bleeding, and (new to me) stroke.
So, I guess, you just pays your money and takes your chance, as they
used to say back in Beaumont in the 1950s.
Also new to me was that non-steroidal anti-inflammatories such as
Tylenol actually INCREASE the risk of OVCA.
As they also said in Beaumont, sometimes you can’t win for losen.
Sunday, July 24, 2022
AN IMPROVED BIO-MARKER?
The Joyce family
Quite som time ago
Nothing very
earth shaking in the anti-OVCA line has crossed my computer lately, but I guess
this is worth reporting. As you surely
know, a large part of the reason OVCA is so deadly is that it is very difficult
to detect until it reaches an advanced stage.
Thus, much effort is expended in trying to develop sensitive bio-marker
routines. That is what my Fred Hutch
research group worked on back then. This
article presents an advance on that front, utilizing a marker protein (HE4)
discovered, if I remember correctly, by my Hutch research group. Catch it early, improve longevity. Not world class news, but welcome nonetheless.
Sunday, July 17, 2022
GOOD HEWS, CHAPTER 3
Two precious creatures
This is
another take on the research, out of Rice University, that had me so excited a
few weeks ago. There is little new here,
but it is pleasing to read this good news again. To capsulize:
It seems to be possible to implant miniscule globules of something that
spews out doses of a potent cancer-killer, Il-2. This not only offs the tumor, it teaches the
immune system what to look for (and kill), thereby fighting metastases as
well. This procedure worked perfectly in
mice. I presume studies involving humans
are in the offing.
I must not
let my hopes climb too high; there are many possible slips lurking out
there. But, Geez!
https://www.wndu.com/2022/06/23/medical-moment-an-implantable-treatment-ovarian-cancer/
Sunday, July 3, 2022
ONE SMALL STEP FORWARD?
Linda, Murphy, and Whiskers
I wrote
earlier of Celsion, the little drug company that could, and its efforts to use
genetics to combat ovarian cancer. This
article announces some encouraging results, and hints at FDA approval. Be sure to notice that this trial was small –
and that Celsion is desperate to raise its stock valuation. I bought a few shares a year or so ago, and
so far have lost over 60% of my initial investment!
In an aside,
I am glad I don’t have to separate cancer victims into a control group and a
group that actually gets the stuff.
Thank God for computers and random-number generators!
https://www.curetoday.com/view/gene-therapy-gen-1-shows-promise-in-treating-advanced-ovarian-cancer
Subscribe to:
Posts (Atom)